Pulse Biosciences, Inc (PLSE) earnings
PLSE earnings moved a median of +1.12% by the close. Quarterly and annual PLSE reports and results, each read against the price at its own news timestamp. Back to the PLSE overview →
33 measured PLSE earnings events.
Where these PLSE earnings landedvs 33 measured PLSE earnings reactions
| Middle 50% of PLSE earnings reactions | -2.25% to +5.22% |
|---|---|
| Median reaction (to close) | +1.12% |
| Measured reactions | 33 |
Point-in-time · zero look-ahead
Half of the 33 PLSE earnings events with a measured close landed between -2.25% and +5.22%; 58% closed up.
| Date | Headline | Event | 5-min | To close |
|---|---|---|---|---|
| Form 10-Q PULSE BIOSCIENCES, INC. For: Jun 30 | SEC filing · Form 10-Q | +2.21% | +12.08% | |
| Pulse Biosciences Reports Business Updates and Second Quarter 2026 Financial Results | Press release | +2.21% | +12.08% | |
| Pulse Biosciences Schedules Second Quarter 2026 Financial Results Conference Call for August 6, 2026 | Press release | +0.56% | +7.66% | |
| Form 10-Q PULSE BIOSCIENCES, INC. For: Mar 31 | SEC filing · Form 10-Q | +0.50% | +13.01% | |
| Pulse Biosciences Reports Business Updates and First Quarter 2026 Financial Results | Press release | +0.63% | -2.25% | |
| Form 10-K/A PULSE BIOSCIENCES, INC. For: Dec 31 | SEC filing · Form 10-K | +0.33% | -2.25% | |
| Form 10-K PULSE BIOSCIENCES, INC. For: Dec 31 | SEC filing · Form 10-K | -4.24% | -12.36% | |
| Form 10-Q PULSE BIOSCIENCES, INC. For: Sep 30 | SEC filing · Form 10-Q | +9.18% | +5.22% | |
| Pulse Biosciences Reports Business Updates and Third Quarter 2025 Financial Results | Press release | +9.18% | +5.22% | |
| Pulse Biosciences Schedules Third Quarter 2025 Business Updates and Financial Results Conference Call for November 5, 2025 | Press release | +0.55% | +0.55% | |
| Form 10-Q PULSE BIOSCIENCES, INC. For: Jun 30 | SEC filing · Form 10-Q | +1.45% | +9.74% | |
| Pulse Biosciences Reports Business Updates and Second Quarter 2025 Financial Results | Press release | +1.45% | +9.74% | |
| Pulse Biosciences Schedules Second Quarter 2025 Business Updates and Financial Results Conference Call for August 12, 2025 | Press release | +1.10% | -0.81% | |
| Form 10-Q PULSE BIOSCIENCES, INC. For: Mar 31 | SEC filing · Form 10-Q | +0.06% | +1.73% | |
| Pulse Biosciences Reports Business Updates and First Quarter 2025 Financial Results | Press release | +0.06% | +1.73% | |
| Form 10-K/A PULSE BIOSCIENCES, INC. For: Dec 31 | SEC filing · Form 10-K | -0.14% | -1.96% | |
| Pulse Biosciences Schedules First Quarter 2025 Financial Results Conference Call for May 8, 2025 | Press release | -1.66% | -7.30% | |
| Form 10-K PULSE BIOSCIENCES, INC. For: Dec 31 | SEC filing · Form 10-K | -2.42% | -0.80% | |
| Form 10-Q PULSE BIOSCIENCES, INC. For: Sep 30 | SEC filing · Form 10-Q | -1.48% | -2.57% | |
| Pulse Biosciences Reports Business Updates and Third Quarter 2024 Financial Results | Press release | -1.48% | -2.57% | |
| Pulse Biosciences Schedules Third Quarter 2024 Financial Results Conference Call for October 30, 2024 | Press release | +2.97% | +3.61% | |
| Form 10-Q PULSE BIOSCIENCES, INC. For: Jun 30 | SEC filing · Form 10-Q | +0.25% | -3.81% | |
| Form NT 10-Q PULSE BIOSCIENCES, INC. For: Jun 30 | SEC filing · Form NT | +0.00% | +1.60% | |
| Pulse Biosciences Reports Business Updates and Preliminary Second Quarter 2024 Financial Results | Press release | +9.32% | +5.03% | |
| Pulse Biosciences Schedules Second Quarter 2024 Financial Results Conference Call for August 12, 2024 | Press release | +1.44% | -8.25% | |
| Form 10-Q Pulse Biosciences, Inc. For: Mar 31 | SEC filing · Form 10-Q | +0.27% | -6.50% | |
| Pulse Biosciences Reports Business Updates and First Quarter 2024 Financial Results | Press release | +0.27% | -6.50% | |
| Pulse Biosciences Schedules First Quarter 2024 Financial Results Conference Call for May 7, 2024 | Press release | +0.15% | +0.00% | |
| Form 10-K Pulse Biosciences, Inc. For: Dec 31 | SEC filing · Form 10-K | -9.33% | +3.50% | |
| Form 10-Q Pulse Biosciences, Inc. For: Sep 30 | SEC filing · Form 10-Q | +3.15% | +5.82% | |
| Pulse Biosciences Reports Business Updates and Third Quarter 2023 Financial Results | Press release | -1.27% | +1.12% | |
| UPDATE Pulse Biosciences Announces New Time for Third Quarter 2023 Financial Results Conference Call | Press release | -1.27% | +1.12% | |
| Pulse Biosciences Schedules Third Quarter 2023 Financial Results Conference Call for November 13, 2023 | Press release | +0.00% | +0.89% |
Keep exploring
More PLSE: analyst actions → · SEC filings → · PLSE overview →
Other Healthcare names and their earnings
| Ticker | Events | Median 30-min | % positive |
|---|---|---|---|
| Bionano Genomics, Inc. (BNGO) | 321 | -0.94% | 31% |
| Wave Life Sciences, Inc. (WVE) | 321 | -0.14% | 45% |
| Voyager Therapeutics, Inc. (VYGR) | 320 | -0.12% | 42% |
| Viking Therapeutics, Inc. (VKTX) | 319 | -0.60% | 43% |
Same sector, same measurement: percent move vs. the price at the news timestamp, read at 30 minutes. Sample sizes differ, so the medians are comparable but the confidence behind them is not. These are each name’s all-news baseline, not its earnings — that is what the link opens.